Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 11/20 | 0.58 |
| ▸ | CA2 | P00918 | 11/20 | 0.58 |
| ▸ | CA12 | O43570 | 10/20 | 0.58 |
| ▸ | CA9 | Q16790 | 10/20 | 0.58 |
| ▸ | MMP1 | P03956 | 1/20 | 0.57 |
| ▸ | MMP2 | P08253 | 1/20 | 0.57 |
| ▸ | MMP9 | P14780 | 1/20 | 0.57 |
| ▸ | MMP8 | P22894 | 1/20 | 0.57 |
| ▸ | MMP13 | P45452 | 1/20 | 0.57 |
| ▸ | CA6 | P23280 | 2/20 | 0.53 |
| ▸ | CA5A | P35218 | 2/20 | 0.53 |
| ▸ | CA7 | P43166 | 2/20 | 0.53 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.53 |
| ▸ | CA4 | P22748 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | NT5E | P21589 | 1/20 | 0.52 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trolamine SCHEMBL339125 | 0.87 | CYP2D6 (0.55) | CYP2D6CYP3A4CA1CA2CA12 | |
| SCHEMBL11516144 | 0.81 | CYP2D6 (1.00) | CYP2D6CYP3A4CA1CA2CA12 | |
| SCHEMBL10790350 | 0.80 | ALDH1A1 (0.62) | CA1CA2CA12CA9MMP1 | |
| SCHEMBL11520559 | 0.79 | CYP2D6 (0.81) | CYP2D6CYP3A4CA1CA2CA12 | |
| SCHEMBL11682917 | 0.79 | CYP2D6 (0.81) | CYP2D6CYP3A4CA1CA2CA12 | |
| SCHEMBL14355362 | 0.78 | ALDH1A1 (0.48) | CYP2D6CYP3A4CA1CA2CA12 | |
| SCHEMBL2563975 | 0.77 | CYP3A4 (0.70) | CYP2D6CYP3A4CA1CA2CA12 | |
| SCHEMBL30380602 | 0.77 | CYP2D6 (0.68) | CYP2D6CYP3A4CA1CA2CA12 | |
| SCHEMBL923761 | 0.76 | CA1 (0.72) | CYP2D6CYP3A4CA1CA2CA12 | |
| SCHEMBL1228868 | 0.76 | MMP1 (0.67) | CYP2D6CYP3A4CA1CA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0741570-B1 | PREVENTING OR REDUCING PHOTOSENSITIVITY AND/OR PHOTOTOXICITY REACTIONS TO ANTIINFECTIVE MEDICATIONS | SEARLE & CO (US) | 2003-05-07 | — | — | EP | claimed |
| EP-0572560-A4 | USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY. | SHAPIRO HOWARD K (US) | 1995-04-26 | — | — | EP | claimed |
| EP-0572560-A1 | USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY | SHAPIRO, Howard, K. (US) | 1993-12-08 | — | — | EP | claimed |
| WO-1992014456-A1 | USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY | SHAPIRO HOWARD K (US) | 1992-09-03 | — | — | WO | claimed |
| CN-103059165-B | Polysaccharide acylate and preparation method thereof | BENGBU BBCA TUSHAN PHARM CO | 2015-04-29 | — | — | CN | disclosed |
| CN-103059165-A | Polysaccharide acylate and preparation method thereof | BENGBU BBCA TUSHAN PHARM CO | 2013-04-24 | — | — | CN | disclosed |
| CN-101784274-A | The method and composition that suppresses edema factor and adenyl cyclase | MISSION PHARMA CO | 2010-07-21 | — | — | CN | disclosed |
| EP-0852499-B1 | THERAPEUTIC AZIDE COMPOUNDS | UNIV GEORGIA RES FOUND (US) | 2010-03-03 | — | — | EP | disclosed |
| US-7122198-B1 | Fast dissolving composition with prolonged sweet taste | PANACEA BIOTEC LIMITED (IN) | 2006-10-17 | — | — | US | disclosed |
| EP-1644046-A2 | CONJUGATED COMPLEMENT CASCADE INHIBITORS | Ortho-McNeil Pharmaceutical, Inc. (US) | 2006-04-12 | — | — | EP | disclosed |
| US-6949521-B2 | Therapeutic azide compounds | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2005-09-27 | — | — | US | disclosed |
| US-20050043253-A1 | Use of wound healing compositions for prevention of infections and allergies | COOK BRADLEY R (US) | 2005-02-24 | — | — | US | disclosed |
| US-6271212-B1 | MIXTURE WITH CARRIER | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC. | 2001-08-07 | — | — | US | disclosed |
| WO-2001039749-A2 | FAST DISSOLVING COMPOSITION WITH PROLONGED SWEET TASTE | PANACEA BIOTEC LIMITED (IN) | 2001-06-07 | — | — | WO | disclosed |
| EP-0852499-A1 | THERAPEUTIC AZIDE COMPOUNDS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1998-07-15 | — | — | EP | disclosed |
| WO-1998002164-A1 | TREATMENT OF EQUINE PROTOZOAL MYELOENCEPHALITIS | MORTAR & PESTLE VETERINARY PHARMACY, INC. (US) | 1998-01-22 | — | — | WO | disclosed |
| WO-1997009052-A1 | THERAPEUTIC AZIDE COMPOUNDS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1997-03-13 | — | — | WO | disclosed |
| EP-0572560-A4 | USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY. | SHAPIRO HOWARD K (US) | 1995-04-26 | — | — | EP | disclosed |
| EP-0572560-A1 | USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY | SHAPIRO, Howard, K. (US) | 1993-12-08 | — | — | EP | disclosed |
| WO-1992014456-A1 | USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY | SHAPIRO HOWARD K (US) | 1992-09-03 | — | — | WO | disclosed |